Gene: AGBL1
Official Full Name: AGBL carboxypeptidase 1provided by HGNC
Gene Summary: Polyglutamylation is a reversible posttranslational modification catalyzed by polyglutamylases that results in the addition of glutamate side chains on the modified protein. This gene encodes a glutamate decarboxylase that catalyzes the deglutamylation of polyglutamylated proteins. Mutations in this gene result in dominant late-onset Fuchs corneal dystrophy. [provided by RefSeq, Nov 2013]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA05338 | AGBL1 Knockout cell line (AC16) | Human | AGBL1 | 1:3-1:4 | negative | Online Inquiry |
| KOA20783 | AGBL1 Knockout cell line (BEAS-2B) | Human | AGBL1 | 1:3~1:4 | negative | Online Inquiry |
| KOA36227 | AGBL1 Knockout cell line (U-2932) | Human | AGBL1 | 1:2-1:4 | negative | Online Inquiry |
| KOA51636 | AGBL1 Knockout cell line (TPC-1) | Human | AGBL1 | 1:5-1:8 | negative | Online Inquiry |
| KOA67043 | AGBL1 Knockout cell line (NCM460) | Human | AGBL1 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.